Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia – real-world analysis of Polish adult leukemia study group

Anita Soboń, Elżbieta Iskierka-Jażdżewska, Joanna Drozd-Sokolowska, Anna Puła, Małgorzata Gajewska, Michał Danecki, Łukasz Bołkun, Agata Ogłoza-Puchowska, Marta Morawska, Janusz Halka, Edyta Subocz, Agnieszka Podgórska, Jagoda Tryc-Szponder, Ewa Paszkiewicz-Kozik, Leszek Czernik, Anna Kopinska, Justyna Rybka, Agnieszka Szymczyk, Kamil Wdowiak, Paweł Steckiewicz, Aleksandra Gołos, Iwona Hus, Krzysztof Jamroziak, Tadeusz Robak, Ewa Lech-Maranda, Bartosz Puła

Open source

DOI: 10.1080/10428194.2026.2690480
Published: 2026-08-10
Container: Leukemia & Lymphoma
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/10428194.2026.2690480,
  title = {Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia – real-world analysis of Polish adult leukemia study group},
  author = {Anita Soboń and Elżbieta Iskierka-Jażdżewska and Joanna Drozd-Sokolowska and Anna Puła and Małgorzata Gajewska and Michał Danecki and Łukasz Bołkun and Agata Ogłoza-Puchowska and Marta Morawska and Janusz Halka and Edyta Subocz and Agnieszka Podgórska and Jagoda Tryc-Szponder and Ewa Paszkiewicz-Kozik and Leszek Czernik and Anna Kopinska and Justyna Rybka and Agnieszka Szymczyk and Kamil Wdowiak and Paweł Steckiewicz and Aleksandra Gołos and Iwona Hus and Krzysztof Jamroziak and Tadeusz Robak and Ewa Lech-Maranda and Bartosz Puła},
  year = {2026},
  journal = {Leukemia \&amp; Lymphoma},
  doi = {10.1080/10428194.2026.2690480},
  url = {https://doi.org/10.1080/10428194.2026.2690480}
}

RIS

TY  - JOUR
TI  - Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia – real-world analysis of Polish adult leukemia study group
AU  - Anita Soboń
AU  - Elżbieta Iskierka-Jażdżewska
AU  - Joanna Drozd-Sokolowska
AU  - Anna Puła
AU  - Małgorzata Gajewska
AU  - Michał Danecki
AU  - Łukasz Bołkun
AU  - Agata Ogłoza-Puchowska
AU  - Marta Morawska
AU  - Janusz Halka
AU  - Edyta Subocz
AU  - Agnieszka Podgórska
AU  - Jagoda Tryc-Szponder
AU  - Ewa Paszkiewicz-Kozik
AU  - Leszek Czernik
AU  - Anna Kopinska
AU  - Justyna Rybka
AU  - Agnieszka Szymczyk
AU  - Kamil Wdowiak
AU  - Paweł Steckiewicz
AU  - Aleksandra Gołos
AU  - Iwona Hus
AU  - Krzysztof Jamroziak
AU  - Tadeusz Robak
AU  - Ewa Lech-Maranda
AU  - Bartosz Puła
PY  - 2026
JO  - Leukemia &amp; Lymphoma
DO  - 10.1080/10428194.2026.2690480
UR  - https://doi.org/10.1080/10428194.2026.2690480
ER  -

APA

Soboń, A., Iskierka-Jażdżewska, E., Drozd-Sokolowska, J., Puła, A., Gajewska, M., Danecki, M., Bołkun, Ł., Ogłoza-Puchowska, A., Morawska, M., Halka, J., Subocz, E., Podgórska, A., Tryc-Szponder, J., Paszkiewicz-Kozik, E., Czernik, L., Kopinska, A., Rybka, J., Szymczyk, A., Wdowiak, K., Steckiewicz, P., Gołos, A., Hus, I., Jamroziak, K., Robak, T., Lech-Maranda, E., & Puła, B. (2026). Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia – real-world analysis of Polish adult leukemia study group. Leukemia & Lymphoma. https://doi.org/10.1080/10428194.2026.2690480

Source records

crossref · retrieved 2026-09-26T06:36:21.244Z